Results 261 to 270 of about 115,105 (360)

Evaluation of ganglion cell complex in patients taking hydroxychloroquine. [PDF]

open access: yesBMC Ophthalmol
Acharya P   +3 more
europepmc   +1 more source

Tofacitinib Use in a Patient With Rheumatoid Arthritis and Polycythemia Vera: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial inflammation and joint destruction, whereas polycythemia vera (PV) is a myeloproliferative neoplasm driven by the Janus kinase (JAK)2 V617F mutation, resulting in erythrocytosis and increased thromboembolic risk.
Milan Bogojevic   +4 more
wiley   +1 more source

Rituximab and Intravenous Immunoglobulin (IVIG) for Refractory Eosinophilic Fasciitis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Eosinophilic fasciitis (EF) is a rare condition with an unknown cause. This case study showed that a 40‐year‐old man with EF did not respond to standard treatments but improved after receiving rituximab and intravenous immunoglobulin (IVIG). Further studies are needed to confirm rituximab's effectiveness and long‐term safety for EF.
Maryam Sahebari   +4 more
wiley   +1 more source

Association Between Pre-hospital Medication Use and Outcomes in Patients Hospitalized for COVID-19 Pneumonia: A Multicenter Observational Study in the Netherlands. [PDF]

open access: yesCureus
Li L   +11 more
europepmc   +1 more source

Moth‐Eaten Pattern of Alopecia in Lichen Planopilaris

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Moth‐eaten pattern of alopecia can be seen in various dermatological conditions, including lichen planopilaris (LPP). Clinical, trichoscopic, and histopathology correlation can give a clue to the etiology of moth‐eaten pattern of alopecia. Since alopecia in LPP is permanent, early recognition and treatment are necessary to prevent progression ...
Sunil Jaiswal   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy